NEW YORK (GenomeWeb) – Precipio said today that it has inked an agreement to jointly offer its ICE COLD-PCR (ICP) mutation enrichment technology with PerkinElmer's NextPrep-Mag cell-free DNA isolation kit, Janus G3 liquid handling workstation, and Chemagic MSM I, Chemagic 360, and Chemagic Prime platforms.

Precipio and PerkinElmer anticipate providing an automated cell-free DNA analysis workflow alongside mutation enrichment technology in ICE COLD-PCR to enable lab-based liquid biopsy testing.

Financial terms of the agreement were not disclosed.